Physician profile
Steven Lu
NPI 1568460186
$602.64
in general payments reported to CMS, 2019-2025
9 companies · $438 in 2025
The $438 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.63 · 2020: $14.83 · 2022: $48.66 · 2024: $25.00 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $180 · Food and Beverage: $177 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $179.98 |
| Food and Beverage | $176.54 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $106.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $179.98 | 2025 | Tremfya |
| Abbott Laboratories | $176.54 | 2025 | Esprit |
| Becton, Dickinson and Company | $106.00 | 2024-2025 | Powerpicc |
| Novartis Pharmaceuticals Corporation | $59.73 | 2019-2020 | |
| Gilead Sciences, INC. | $17.79 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.58 | 2022 | |
| Merck Sharp & Dohme LLC | $16.19 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.54 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.